Simvastatin: between clinics and health economics

Statins reduce the incidence of cardiovascular events, one of the most important public health problems and among the main leading causes of death. Their use has been increasing in the last decade and today they represent the first drug class in terms of public expenditure. In view of the introducti...

Full description

Bibliographic Details
Main Authors: Francesco Vittorio Costa, Orietta Zaniolo
Format: Article
Language:English
Published: SEEd Medical Publishers 2007-03-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/253